Our Best Shot - CHI’s Mandatory COVID-19 Vaccination Policy

CHI has instituted a mandatory vaccination policy for all in-person participants across all our events. Learn more about our health and safety protocols.

Learn More »

View By:

Topic

Date

Immunogenicity Assessment and Management

Improving Immunotherapy Efficacy and Safety

Characterization for Novel Biotherapeutics

Difficult-to-Express Proteins

Antibodies for Cancer Therapy

Display of Biologics

Cell-Based Immunotherapies

Biophysical Methods

Engineering Antibodies

Optimizing Protein Expression

Emerging Targets and Novel Approaches for Oncology & Beyond

Immunogenicity Assessment and Management

Advancing Bispecific Antibodies and Combination Therapy to the Clinic

Next Generation Immunotherapies

Gene Therapy R&D Analytics

Maximizing Protein Production Workflows

Driving Clinical Success in Antibody Drug Conjugates

Machine Learning Approaches for Protein Engineering

Engineering Bispecific Antibodies

Experience the Future of Biotherapeutic Drug Development
at the World’s Leading Biologics Event

PEGS Boston Returns In-Person in 2022

Now in its eighteenth year, the PEGS Boston Summit is recognized as the leading international meeting place for the biotherapeutics community. PEGS Boston highlights a wide spectrum of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytical, immunogenicity, and more.

As we navigate the new realities of conferences and gatherings, you can count on CHI’s commitment to deliver quality content and facilitated networking opportunities to help achieve your research goals. Our new hybrid event model gives you the option to experience the summit safely in-person or securely online.

Join your peers and colleagues from around the world at PEGS Boston Summit to share insights, case studies, cutting-edge research, and form collaborations to advance biotherapeutics development.

Browse 2022 Programs